{"id":"pq-supervised","safety":{"commonSideEffects":[{"rate":null,"effect":"Hemolytic anemia (in G6PD-deficient patients)"},{"rate":null,"effect":"Abdominal discomfort"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Methemoglobinemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PQ supervised refers to a supervised administration protocol for primaquine, an 8-aminoquinoline antimalarial drug used to eliminate hypnozoites (dormant liver stages) of Plasmodium vivax and P. ovale. The 'supervised' component ensures adherence and tolerability monitoring, particularly important given primaquine's potential for hemolytic toxicity in glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals.","oneSentence":"PQ supervised is a directly observed therapy (DOT) program for primaquine administration in malaria treatment.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:02:01.860Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Malaria caused by Plasmodium vivax (radical cure to prevent relapse)"},{"name":"Malaria caused by Plasmodium ovale (radical cure to prevent relapse)"}]},"trialDetails":[{"nctId":"NCT02802813","phase":"PHASE1, PHASE2","title":"P.Vivax Treatment Trial","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2016-06-14","conditions":"Plasmodium Vivax","enrollment":41},{"nctId":"NCT02787070","phase":"PHASE4","title":"A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)","status":"COMPLETED","sponsor":"Menzies School of Health Research","startDate":"2016-09-14","conditions":"Uncomplicated Malaria","enrollment":420}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":27,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"PQ supervised","genericName":"PQ supervised","companyName":"Menzies School of Health Research","companyId":"menzies-school-of-health-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PQ supervised is a directly observed therapy (DOT) program for primaquine administration in malaria treatment. Used for Plasmodium vivax malaria (radical cure and relapse prevention), Plasmodium ovale malaria (radical cure and relapse prevention).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}